Propiedad y actividad de insiders de PMV Pharmaceuticals, Inc. (PMVP): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.43 |
| Capitalización | $76M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $30.3M | $73.3M | $361.4M | $172.5M | $108.3M | $37.7M | $40.9M | $38.0M |
| Inversiones a Corto | $31.6M | $28.2M | 0 | $124.7M | $132.8M | $165.4M | $128.6M | $75.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $62.2M | $102.1M | $364.8M | $301.3M | $247.0M | $207.4M | $175.7M | $115.2M |
| Inmovilizado Material | $1.0M | $739000 | $569000 | $13.2M | $20.5M | $19.0M | $1.6M | $1.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $63.5M | $103.0M | $365.5M | $331.6M | $270.3M | $252.2M | $191.3M | $116.6M |
| Cuentas por Pagar | $1.0M | $2.8M | $1.6M | $3.2M | $3.0M | $3.2M | $6.6M | $3.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $352000 | 0 |
| Pasivos Corrientes | $2.3M | $4.5M | $6.4M | $12.2M | $10.8M | $14.0M | $14.4M | $11.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $435000 |
| Pasivos Totales | $109.6M | $173.5M | $6.4M | $23.0M | $24.3M | $26.5M | $15.2M | $11.8M |
| Reservas | -$50.1M | -$75.4M | -$109.9M | -$167.7M | -$241.0M | -$310.0M | -$368.7M | -$446.5M |
| Patrimonio Neto | -$46.1M | -$70.5M | $359.1M | $308.6M | $246.0M | $225.7M | $176.1M | $104.7M |
| Deuda Total | $107.2M | 0 | 0 | $11.2M | $14.0M | $13.3M | $1.2M | $838000 |
| Deuda Neta | $45.3M | -$101.5M | -$361.4M | -$286.0M | -$227.1M | -$189.8M | -$168.3M | -$112.1M |
| Capital Circulante | $59.9M | $97.6M | $358.4M | $289.1M | $236.2M | $193.4M | $161.3M | $103.8M |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 7.70 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -3.41 |
Rentabilidad
| Rentabilidad sobre capital | -78.11% |
| Rentabilidad sobre capital invertido | -111.08% |
| Rentabilidad sobre activos | -91.66% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ACRV · ATYR · BMEA · CBUS · IMUX · LITS · RLMD
Explorar sector: Healthcare · Biotechnology
Más secciones de PMVP: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones